Leica Biosystems is a global leader in anatomic pathology and cancer diagnostics, providing end-to-end workflow solutions from biopsy to diagnosis. Founded in 1872 and headquartered in Nussloch, Germany, the company is a division of Danaher Corporation. With a workforce of 1,001 to 5,000 employees, Leica Biosystems operates internationally, with major locations in the UK, Netherlands, Australia, China, Brazil, and the United States. The company specializes in comprehensive laboratory workflow solutions, including sample preparation, staining technologies, imaging, and digital pathology. Leica Biosystems empowers clinicians with innovative tools for accurate cancer diagnostics, enabling over 1.6 million diagnoses each week. Its product portfolio includes precision instruments, staining consumables, digital pathology software, and specialized solutions for neuropathology and histopathology. By integrating the full pathology workflow, Leica Biosystems enhances efficiency and improves patient outcomes in the healthcare sector.